You need to enable JavaScript to run this app.
Recon: WHO cites concerns about Sputnik V plant; GSK’s drug arm to get $11B windfall from consumer spin-off
Recon
Michael Mezher
Biologics
Biotechnology
Combination Products
Diagnostics
Medical Devices
Pharmaceuticals